NCT03734341

Brief Summary

This study compares the titration pressures achieved through two auto-titrating modalities, a new incremental fixed pressure mode versus routine auto-adjusting pressure mode, in CPAP-naïve obstructive sleep apnea patients. The aim of the study is to verify that this new modality achieves a lower titration pressure.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Apr 2018

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2018

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2018

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

November 6, 2018

Completed
1 day until next milestone

First Posted

Study publicly available on registry

November 7, 2018

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 7, 2019

Completed
Last Updated

January 9, 2019

Status Verified

January 1, 2019

Enrollment Period

5 months

First QC Date

November 6, 2018

Last Update Submit

January 7, 2019

Conditions

Keywords

CPAPTitrationObstructive Sleep ApneaTelemonitoringTelemedicine

Outcome Measures

Primary Outcomes (1)

  • Titration pressure

    Titration pressure in any modality

    14-day maximum period

Secondary Outcomes (2)

  • CPAP Adherence

    14-day period

  • CPAP Efficacy

    14-day period

Study Arms (2)

EZ START Titration

EXPERIMENTAL

CPAP titration test performed with an auto CPAP device preset on incremental fixed pressure modality. If the titration pressure is achieved (in a 14-day maximum period) the device will be immediately and remotely preset in CPAP modality with EZ START pressure (if any) for a 14-day period to check the titration pressure performance in a short-time period. Afterwards, the device will be remotely preset on the next modality: auto-adjusting pressure (no wash-out period).

Device: EZ START TitrationDevice: APAP Titration

APAP Titration

ACTIVE COMPARATOR

CPAP titration test performed with an auto CPAP device preset on auto-adjusting pressure modality. If the titration pressure is achieved (in a 14-day maximum period) the device will be immediately and remotely preset in CPAP modality with APAP pressure (if any) for a 14-day period to check the titration pressure performance in a short-time period. Afterwards, the device will be remotely preset on the next modality: incremental fixed pressure (no wash-out period).

Device: EZ START TitrationDevice: APAP Titration

Interventions

The auto CPAP device gradually increases air pressure night-by-night until the preset therapeutic pressure is reached. Pressure range: from 5 to 14 cmH2O. Ramp: 4cmH2O, 20 minutes. Mask: nasal (if no contraindication). Titration pressure: fixed pressure that reduces rAHI below 10, mask leak below 10% of the session, time session above 4 hours.

Also known as: DreamStation auto CPAP, Philips Respironics, EncoreAnywhere
APAP TitrationEZ START Titration

The auto CPAP device continuously adjusts the pressure in real time to the minimum pressure needed to maintain upper airway patency at any moment. Pressure range: 5 to 14 cm H2O. Ramp: 4cmH2O, 20 minutes. Mask: nasal (if no contraindication). Titration pressure: visual analysis pressure that reduces rAHI below 10 during 90% of the session, mask leak below 10% of the session, therapeutic session above 4 hours.

Also known as: DreamStation auto CPAP, Philips Respironics, EncoreAnywhere
APAP TitrationEZ START Titration

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 18-80
  • OSA diagnosis
  • CPAP therapy indication

You may not qualify if:

  • Previous CPAP therapy
  • Severe COPD
  • Respiratory insufficiency
  • Obesity-hypoventilation syndrome
  • Cardiac failure
  • Recent cerebrovascular disease
  • Central apnea, Cheyne Stokes or similar
  • Important nasal insufficiency or malformation
  • Previous pharyngeal surgery
  • Shift work
  • Psychosocial disability
  • Refusal to participate

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital Universitario Araba

Vitoria-Gasteiz, Alava, 01004, Spain

Location

Related Publications (4)

  • Kushida CA, Chediak A, Berry RB, Brown LK, Gozal D, Iber C, Parthasarathy S, Quan SF, Rowley JA; Positive Airway Pressure Titration Task Force; American Academy of Sleep Medicine. Clinical guidelines for the manual titration of positive airway pressure in patients with obstructive sleep apnea. J Clin Sleep Med. 2008 Apr 15;4(2):157-71.

    PMID: 18468315BACKGROUND
  • Masa JF, Jimenez A, Duran J, Capote F, Monasterio C, Mayos M, Teran J, Hernandez L, Barbe F, Maimo A, Rubio M, Montserrat JM. Alternative methods of titrating continuous positive airway pressure: a large multicenter study. Am J Respir Crit Care Med. 2004 Dec 1;170(11):1218-24. doi: 10.1164/rccm.200312-1787OC. Epub 2004 Jul 28.

    PMID: 15282204BACKGROUND
  • McArdle N, Singh B, Murphy M, Gain KR, Maguire C, Mutch S, Hillman DR. Continuous positive airway pressure titration for obstructive sleep apnoea: automatic versus manual titration. Thorax. 2010 Jul;65(7):606-11. doi: 10.1136/thx.2009.116756.

    PMID: 20627917BACKGROUND
  • Ahmed O, Parthasarathy S. APAP and Alternative Titration Methods. Sleep Med Clin. 2010 Sep 1;5(3):361-368. doi: 10.1016/j.jsmc.2010.05.010.

    PMID: 20806054BACKGROUND

MeSH Terms

Conditions

ApneaSleep Apnea SyndromesSleep Apnea, ObstructiveRespiratory AspirationSleep Wake DisordersRespiratory Tract DiseasesSleep Disorders, Intrinsic

Condition Hierarchy (Ancestors)

Respiration DisordersSigns and Symptoms, RespiratorySigns and SymptomsPathological Conditions, Signs and SymptomsDyssomniasNervous System DiseasesPathologic ProcessesNeurologic ManifestationsMental Disorders

Study Officials

  • Mikel Azpiazu, MD

    Basque Health Service

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

November 6, 2018

First Posted

November 7, 2018

Study Start

April 1, 2018

Primary Completion

September 1, 2018

Study Completion

January 7, 2019

Last Updated

January 9, 2019

Record last verified: 2019-01

Data Sharing

IPD Sharing
Will not share

Locations